Annual EBITDA
-$19.72 M
+$1.77 M+8.24%
December 31, 2023
Summary
- As of February 7, 2025, PPBT annual EBITDA is -$19.72 million, with the most recent change of +$1.77 million (+8.24%) on December 31, 2023.
- During the last 3 years, PPBT annual EBITDA has risen by +$8.69 million (+30.58%).
- PPBT annual EBITDA is now -664.42% below its all-time high of -$2.58 million, reached on December 31, 2013.
Performance
PPBT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$108.00 K
+$2.23 M+95.39%
September 1, 2024
Summary
- As of February 7, 2025, PPBT quarterly EBITDA is -$108.00 thousand, with the most recent change of +$2.23 million (+95.39%) on September 1, 2024.
- Over the past year, PPBT quarterly EBITDA has increased by +$3.61 million (+97.09%).
- PPBT quarterly EBITDA is now at all-time high.
Performance
PPBT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$11.14 M
+$4.88 M+30.46%
September 1, 2024
Summary
- As of February 7, 2025, PPBT TTM EBITDA is -$11.14 million, with the most recent change of +$4.88 million (+30.46%) on September 1, 2024.
- Over the past year, PPBT TTM EBITDA has increased by +$7.50 million (+40.22%).
- PPBT TTM EBITDA is now -901.26% below its all-time high of -$1.11 million, reached on September 1, 2014.
Performance
PPBT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PPBT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.2% | +97.1% | +40.2% |
| 3 y3 years | +30.6% | +97.7% | +44.9% |
| 5 y5 years | -255.2% | - | - |
PPBT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.6% | +8.2% | at high | +98.5% | at high | +48.1% |
| 5 y | 5-year | -299.8% | +30.6% | at high | +98.5% | -75.0% | +48.1% |
| alltime | all time | -664.4% | +30.6% | at high | +98.5% | -901.3% | +48.1% |
Purple Biotech EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$108.00 K(-95.4%) | -$11.14 M(-30.5%) |
| Jun 2024 | - | -$2.34 M(-37.0%) | -$16.02 M(-14.0%) |
| Mar 2024 | - | -$3.72 M(-25.4%) | -$18.64 M(-5.5%) |
| Dec 2023 | -$19.72 M(-8.2%) | -$4.98 M(-0.2%) | -$19.72 M(-5.1%) |
| Sep 2023 | - | -$4.99 M(+0.6%) | -$20.78 M(+1.0%) |
| Jun 2023 | - | -$4.96 M(+3.4%) | -$20.58 M(+7.9%) |
| Mar 2023 | - | -$4.80 M(-20.5%) | -$19.07 M(-11.3%) |
| Dec 2022 | -$21.49 M(+22.7%) | -$6.03 M(+26.1%) | -$21.49 M(+6.3%) |
| Sep 2022 | - | -$4.79 M(+38.8%) | -$20.21 M(+10.2%) |
| Jun 2022 | - | -$3.45 M(-52.3%) | -$18.34 M(-0.2%) |
| Mar 2022 | - | -$7.22 M(+51.9%) | -$18.37 M(+4.9%) |
| Dec 2021 | -$17.52 M | -$4.75 M(+63.3%) | -$17.52 M(+37.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$2.91 M(-16.4%) | -$12.76 M(+29.6%) |
| Jun 2021 | - | -$3.48 M(-45.3%) | -$9.85 M(+54.7%) |
| Mar 2021 | - | -$6.37 M(+281.3%) | -$6.37 M(+147.6%) |
| Dec 2020 | -$28.41 M(+475.9%) | - | - |
| Dec 2019 | -$4.93 M(-11.2%) | - | - |
| Dec 2018 | -$5.55 M(-56.9%) | - | - |
| Dec 2017 | -$12.88 M(+6.3%) | - | - |
| Dec 2016 | -$12.12 M(+188.6%) | - | - |
| Dec 2015 | -$4.20 M(-19.7%) | -$1.67 M(+85.1%) | -$2.57 M(+35.5%) |
| Sep 2015 | - | -$902.00 K(-9.4%) | -$1.90 M(-10.0%) |
| Dec 2014 | -$5.23 M(+102.8%) | -$996.00 K(-10.5%) | -$2.11 M(+89.5%) |
| Sep 2014 | - | -$1.11 M | -$1.11 M |
| Dec 2013 | -$2.58 M | - | - |
FAQ
- What is Purple Biotech annual EBITDA?
- What is the all time high annual EBITDA for Purple Biotech?
- What is Purple Biotech annual EBITDA year-on-year change?
- What is Purple Biotech quarterly EBITDA?
- What is the all time high quarterly EBITDA for Purple Biotech?
- What is Purple Biotech quarterly EBITDA year-on-year change?
- What is Purple Biotech TTM EBITDA?
- What is the all time high TTM EBITDA for Purple Biotech?
- What is Purple Biotech TTM EBITDA year-on-year change?
What is Purple Biotech annual EBITDA?
The current annual EBITDA of PPBT is -$19.72 M
What is the all time high annual EBITDA for Purple Biotech?
Purple Biotech all-time high annual EBITDA is -$2.58 M
What is Purple Biotech annual EBITDA year-on-year change?
Over the past year, PPBT annual EBITDA has changed by +$1.77 M (+8.24%)
What is Purple Biotech quarterly EBITDA?
The current quarterly EBITDA of PPBT is -$108.00 K
What is the all time high quarterly EBITDA for Purple Biotech?
Purple Biotech all-time high quarterly EBITDA is -$108.00 K
What is Purple Biotech quarterly EBITDA year-on-year change?
Over the past year, PPBT quarterly EBITDA has changed by +$3.61 M (+97.09%)
What is Purple Biotech TTM EBITDA?
The current TTM EBITDA of PPBT is -$11.14 M
What is the all time high TTM EBITDA for Purple Biotech?
Purple Biotech all-time high TTM EBITDA is -$1.11 M
What is Purple Biotech TTM EBITDA year-on-year change?
Over the past year, PPBT TTM EBITDA has changed by +$7.50 M (+40.22%)